ACG Wealth’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-53,023
Closed -$5.26M 356
2019
Q3
$5.26M Sell
53,023
-3,644
-6% -$346K 0.78% 31
2019
Q2
$5.24M Buy
56,667
+8,569
+18% +$814K 0.7% 38
2019
Q1
$4.54M Buy
48,098
+1,432
+3% +$125K 0.61% 43
2018
Q4
$2.99M Buy
46,666
+18,067
+63% +$1.33M 0.46% 57
2018
Q3
$2.56M Buy
28,599
+3,591
+14% +$317K 0.34% 69
2018
Q2
$1.99M Buy
25,008
+121
+0.5% +$10K 0.3% 75
2018
Q1
$2.22M Sell
24,887
-7,134
-22% -$685K 0.34% 77
2017
Q4
$3.34M Buy
32,021
+6,228
+24% +$703K 0.49% 54
2017
Q3
$3.76M Buy
25,793
+1,784
+7% +$243K 0.66% 41
2017
Q2
$3.12M Buy
24,009
+646
+3% +$79.2K 0.51% 50
2017
Q1
$2.91M Buy
23,363
+242
+1% +$29K 0.53% 52
2016
Q4
$2.68M Sell
23,121
-1,198
-5% -$133K 0.57% 50
2016
Q3
$2.54M Sell
24,319
-2,567
-10% -$278K 0.54% 54
2016
Q2
$2.65M Sell
26,886
-273
-1% -$28.2K 0.59% 49
2016
Q1
$2.72M Sell
27,159
-1,308
-5% -$135K 0.61% 47
2015
Q4
$3.41M Buy
28,467
+1,609
+6% +$186K 0.76% 35
2015
Q3
$2.9M Buy
26,858
+2,996
+13% +$372K 0.78% 36
2015
Q2
$2.76M Sell
23,862
-912
-4% -$104K 0.69% 41
2015
Q1
$2.86M Sell
24,774
-1,265
-5% -$151K 0.75% 40
2014
Q4
$2.91M Buy
26,039
+278
+1% +$29.3K 0.79% 32
2014
Q3
$2.44M Sell
25,761
-25,256
-50% -$2.28M 0.69% 48
2014
Q2
$4.38M Buy
51,017
+25,595
+101% +$1.95M 0.83% 45
2014
Q1
$1.77M Sell
25,422
-10,620
-29% -$841K 0.53% 59
2013
Q4
$3.04M Sell
36,042
-608
-2% -$48.1K 0.78% 42
2013
Q3
$2.83M Sell
36,650
-4,630
-11% -$324K 1.17% 18
2013
Q2
$2.41M Buy
+41,280
New +$2.48M 0.94% 31

Other funds holding CELG

ACG Wealth's CELG Position: Q4 2019 in Review

ACG Wealth sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 53,023 shares — an estimated $5.26M sold.

ACG Wealth first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.26M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ACG Wealth reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ACG Wealth sold 53,023 Celgene Corp shares in Q4 2019, an estimated $5.26M.
  • ACG Wealth first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ACG Wealth's Celgene Corp position peaked at $5.26M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ACG Wealth's 13F filing for Q4 2019, filed 13 Feb 2020.